Cellromax Science Co., Ltd. (KOSDAQ: A471820)
Financials · Capital Markets · KR
₩4,120.00
-0.36% today · -23.8% 1Y
Cellromax Science Co., Ltd. (KOSDAQ: A471820) operates in the Capital Markets industry within the Financials sector. The company is valued at $32.18M.
Over the last twelve months the share price has lost 23.8%, trading between 3.41K and 7.69K.
Tweenvest scores Cellromax Science Co., Ltd. across four factors: quality 73/100, value 76/100, dividend 90/100. Its strongest factor is dividend.
A471820 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.18M
- Revenue (TTM)
- $13.78M
- P/E
- 13.64
- EPS
- 302.14
- Dividend yield
- 4.49%
- Beta (5Y)
- —
- 52-week high
- ₩7,690.00
- 52-week low
- ₩3,410.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.04M
- Employees
- —
- Next earnings
- —
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $215.34 | +0.59% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,055.16 | +1.82% |
Figures last refreshed Aug 18, 2026.